Professor, Internal Medicine, University of Michigan
Cardiology
Dr. Keith D. Aaronson, MD
|
|
Give Review
Keith Aaronson practices Cardiology. He graduated from Baylor College of Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Keith D. Aaronson is a published doctor and has 99 publications published. The lastest was: 'Reevaluating the significance of pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversi...' He is registered with Medicare and accepts Medicare payments.
Publications
- The HeartMate II Risk Score: an Adjusted Score for evaluation of all continuous flow left ventricular assist devices.
- Identification and Management of Pump Thrombus in the HeartWare Left Ventricular Assist Device System: A Novel Approach Using Log File Analysis.
- Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
- Gastrointestinal Bleeding in Recipients of the HeartWare Ventricular Assist System.
- Uncorrected pre-operative mitral Valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation.
- An examination of survival by sex and race in the HeartWare Ventricular Assist Device for the Treatment of Advanced Heart Failure (ADVANCE) Bridge to Transplant (BTT) ...
- Consequences of Aortic insufficiency during long-term axial continuous-flow left ventricular assist device support.
- Drive-line infections and sepsis in patients receiving the HVAD system as a left ventricular assist device.
- Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac Valve procedures.
- Impact of left ventricular assist device on diabetes management: an evaluation through case analysis and clinical impact.
- Vitamin D Receptor Genetics on Extracellular Matrix Biomarkers and Hemodynamics in Systolic Heart Failure.
- Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
- An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
- Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
- Preoperative Atrial Fibrillation Increases Risk of Thromboembolic Events After Left Ventricular Assist Device Implantation.
- HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial.
- Baseline Albumin Is Associated with Worsening Renal Function in Patients with Acute Decompensated Heart Failure Receiving Continuous Infusion Loop Diuretics.
- Effect of obesity on in-hospital treatment for Acute coronary syndrome complicated by new-onset heart failure.
- Statement Regarding the Pre and Post Market Assessment of Durable, Implantable Ventricular Assist Devices in the United States: Executive Summary: Endorsed by The Soci...
- Statement Regarding the Pre and Post Market Assessment of Durable, Implantable Ventricular Assist Devices in the United States: Endorsed by The Society of Thoracic Sur...
- Device Exchange After Primary Left Ventricular Assist Device Implantation: Indications and Outcomes.
- Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation.
- Heart failure prognostic models: why bother?
- The effectiveness of United Network of Organ Sharing status 2 transplantation in the modern era.
- Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to Heart transplantation: a pros...
- Left ventricular assist device management in patients chronically supported for advanced Heart failure.
- The development of Aortic insufficiency in left ventricular assist device-supported patients.
- Letter by Dardas and Aaronson regarding article, "Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patient...
- Relationship between obesity and resting energy expenditure in systolic Heart failure.
- Diagnosis and management of right-sided Heart failure in subjects supported with left ventricular assist devices.
- Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
- Model for end-stage liver Disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality.
- A restrictive inflow pattern does not predict implantable cardioverter-defibrillator therapy in primary prevention.
- Sex matters, but to what clinical avail?
- Relation of body mass index to mortality after development of heart failure due to Acute coronary syndrome.
- Right-sided Heart failure: diagnosis and treatment strategies.
- The right ventricular Failure risk score a pre-operative tool for assessing the risk of right ventricular Failure in left ventricular assist device candidates.
- Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices.
- Heart transplantation: assessment of Heart failure mortality risk.
- Nesiritide for Acute decompensated heart failure: does the benefit justify the risk?
- Identification of device malfunction in patients supported with the HeartMate XVE left ventricular assist system.
- Risk of death associated with nesiritide in patients with Acutely decompensated heart failure.
- CRT-D therapy in Heart failure: how much do NYHA class IV patients benefit?
- Prophylactic pacemaker use to allow beta-blocker therapy in patients with chronic Heart failure with bradycardia.
- Nesiritide--not verified.
- The prevalence and pattern of complementary and alternative supplement use in individuals with chronic Heart failure.
- Effect of oral vitamin E and C therapy on calcineurin inhibitor levels in Heart transplant recipients.
- Risk of worsening renal function with nesiritide in patients with Acutely decompensated heart failure.
- Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced Heart failure.
- Impact of mitral Valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction.
- Discharge education improves clinical outcomes in patients with chronic Heart failure.
- Brain natriuretic peptide predicts serious cardiac allograft rejection independent of hemodynamic measurements.
- Spironolactone-induced renal insufficiency and hyperkalemia in patients with Heart failure.
- Heart failure survival score continues to predict clinical outcomes in patients with Heart failure receiving beta-blockers.
- Barriers to constraining health care cost growth.
- Predicting survival in ambulatory patients with severe Heart failure on beta-blocker therapy.
- Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha).
- Patient selection for left ventricular assist device therapy.
- Treating Hypertension: a new chapter. Do whatever it takes to hit your blood-pressure target.
- Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation.
- Impact of serial changes in cardiac hemodynamics on exercise performance in patients with Heart failure due to ischemic and nonischemic cardiomyopathy.
- Prognostic significance of Mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction.
- Left ventricular assist device therapy improves utilization of donor Hearts.
- Safety and efficacy of atorvastatin in Heart transplant recipients.
- Short-term risk of death after treatment with nesiritide for decompensated Heart failure: a pooled analysis of randomized controlled trials.
- Serial assessment of exercise capacity after Heart transplantation.
- Sex differences in patient acceptance of cardiac transplant candidacy.
- Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe Heart fail...
- Coupling of hemodynamic measurements with oxygen consumption during exercise does not improve risk stratification in patients with Heart failure.
- Bone loss and turnover after cardiac transplantation.
- Mitral Valve replacement and tricuspid Valve repair after cardiac transplantation.
- Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation.
- Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive Heart failure.
- Reevaluating the significance of Pulmonary hypertension before cardiac transplantation: determination of optimal thresholds and quantification of the effect of reversi...
- Mortality remains high for outpatient transplant candidates with prolonged (>6 months) waiting list time.
- Extracorporeal life support to left ventricular assist device bridge to Heart transplant: A strategy to optimize survival and resource utilization.
- Peak VO(2): a simple yet enduring standard.
- Exercise for Heart failure?
- Doppler-derived dP/dt and -dP/dt predict survival in congestive Heart failure.
- My mother was recently diagnosed with Graves' Disease. Does this mean I'm more likely to develop it?
- I've heard that eating foods high in potassium can help lower blood pressure and prevent stroke. But can too much potassium be dangerous?
- Assessment of an extracorporeal life support to LVAD bridge to Heart transplant strategy.
- The use of extracorporeal life support in adult patients with primary cardiac Failure as a bridge to implantable left ventricular assist device.
- Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft re...
- Heart retransplantation.
- Use of a continuous-flow device in patients awaiting Heart transplantation.
- Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
- Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial.
- Neurocognitive assessments in advanced Heart failure patients receiving continuous-flow left ventricular assist devices.
- The cost of medical management in advanced Heart failure during the final two years of life.
- The effect of Crataegus oxycantha Special Extract WS 1442 on clinical progression in patients with mild to moderate symptoms of Heart failure.
- Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced Heart failure patients.
- Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary.
- Patient selection for left ventricular assist devices.
- Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.
- Left ventricular assist devices as permanent Heart failure therapy: the price of progress.
- Listing criteria for Heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.
- More hope for Heart failure. Findings suggest expanded use of aldosterone-blockers.
Schools
Baylor University
University Mich Med Center
Hospital Of The University Penn
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania Health System -
University of Michigan Hospitals and Health Centers -
Baylor College of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1144305301 | |
| NPPES Provider LastName | AARONSON | |
| NPPES Provider FirstName | KEITH | |
| NPPES Provider ZIPCode | 481095856 | |
| NPPES Provider State | MI | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1827.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144305301 |
| Last Name Of The Provider | AARONSON |
| First Name Of The Provider | KEITH |
| View All |
Similar Doctors
|
|
Dr. Claire S. Duvernoy, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer C. Matthews, MD |
|
|
Dr. David J. Pinsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley J. Chetcuti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Njeri Thande, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott H. Visovatti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodore J. Kolias, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael P. Thomas, MD |